ArticleFrontiers in immunology2021

Tumor Flare Reaction in a Classic Hodgkin Lymphoma Patient Treated With Brentuximab Vedotin and Tislelizumab: A Case Report.

Chunting Zhu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.